Chapter 4 Global Market for Emerging Insulin Drug and Delivery Technologies, by Type
- Overview
- Technological Advances in Insulin Syringes
- Insulin Delivery Pen Devices
- Disposable Insulin Pens
- Reusable Insulin Pens
- Technological Advances in Insulin Drug and Delivery Pen Devices
- External Insulin Pumps
- Technological Advances in Insulin Pump Systems
- Implantable Insulin Pumps
- Closed-Loop Artificial Pancreas
- Bionic Pancreas
- Smart Pens
Chapter 5 Global Market for Emerging Insulin Drug Delivery Devices, by Application
- Overview
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
Chapter 6 Global Market for Insulin Drug Delivery Devices, by Region
- Overview
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 8 Sustainability in the Insulin Drug and Delivery Market: An ESG Perspective
- Introduction
- ESG Performance Analysis
List of Tables
Summary Table: Global Market for Emerging Insulin Drug Delivery Devices, by Type, Through 2028
Table 1: Latest Data for Diabetes Globally, 2021 and 2045
Table 2: Global Estimates and Projections for Diabetes, 2019-2045
Table 3: Diabetes Cases, by Country, 2000-2045
Table 4: Age-Adjusted Comparative Prevalence of Diabetes, by Region, 2010-2045
Table 5: First-Time Generic Drug Approvals for Type 2 Diabetes, July 2022 to August 2022
Table 6: Global Market for Insulin Syringes and Vials, Through 2028
Table 7: Global Market for Insulin Syringes, by Type, Through 2028
Table 8: Leading Manufacturers of Insulin Syringes and Insulin Syringe Products, 2022
Table 9: Commercially Available Insulin Injector Pens
Table 10: Leading Manufacturers of External Insulin PumpsLeading Manufacturers of External Insulin Pumps
Table 11: Features of Current Leading Insulin Pump Systems
Table 12: Global Market for Emerging Insulin Drug Delivery Devices, by Type, Through 2028
Table 13: Global Market for Emerging Insulin Drug Delivery Devices, by Region, Through 2028
Table 14: Global Market for Insulin Syringes and Vials, by Region, Through 2028
Table 15: Global Market for Insulin Pens, by Region, Through 2028
Table 16: Global Market for Insulin Pumps, by Region, Through 2028
Table 17: Global Market for Smart Pens, by Region, Through 2028
Table 18: Global Market for Insulin Vials, by Region, Through 2028
Table 19: Global Market for Insulin Syringes, by Region, Through 2028
Table 20: Global Market for U-100 Insulin Syringes, by Region, Through 2028
Table 21: Global Market for U-40 Insulin Syringes, by Region, Through 2028
Table 22: Global Market for Emerging Insulin Drug Delivery Devices, by Application, Through 2028
Table 23: Global Market for Type 1 Diabetes, by Region, Through 2028
Table 24: Global Market for Type 2 Diabetes, by Region, Through 2028
Table 25: Global Market for Gestational Diabetes, by Region, Through 2028
Table 26: Global Market for Emerging Insulin Drug Delivery Devices, by Region, Through 2028
Table 27: North American Market for Insulin Drug Delivery Devices, by Country, Through 2028
Table 28: North American Market for Insulin Drug Delivery Devices, by Type, Through 2028
Table 29: North American Market for Insulin Syringes and Vials, by Segment, Through 2028
Table 30: North American Market for Insulin Syringes, by Type, Through 2028
Table 31: North American Market for Insulin Drug Delivery Devices, by Application, Through 2028
Table 32: European Market for Insulin Drug Delivery Devices, by Country, Through 2028
Table 33: European Market for Insulin Drug Delivery Devices, by Type, Through 2028
Table 34: European Market for Insulin Syringes and Vials, by Segment, Through 2028
Table 35: European Market for Insulin Syringes, by Type, Through 2028
Table 36: European Market for Insulin Drug Delivery Devices, by Application, Through 2028
Table 37: Asia-Pacific Market for Insulin Drug Delivery Devices, by Country, Through 2028
Table 38: Asia-Pacific Market for Insulin Drug Delivery Devices, by Type, Through 2028
Table 39: Asia-Pacific Market for Insulin Syringes and Vials, by Segment, Through 2028
Table 40: Asia-Pacific Market for Insulin Syringes, by Type, Through 2028
Table 41: Asia-Pacific Market for Insulin Drug Delivery Devices, by Application, Through 2028
Table 42: RoW Market for Insulin Drug Delivery Devices, by Sub-region, Through 2028
Table 43: RoW Market for Insulin Drug Delivery Devices, by Type, Through 2028
Table 44: RoW Market for Insulin Syringes and Vials, by Segment, Through 2028
Table 45: RoW Market for Insulin Syringes, by Type, Through 2028
Table 46: RoW Market for Insulin Drug Delivery Devices, by Application, Through 2028
Table 47: ESG Performance Analysis of the Market for Insulin Drug and Delivery Technologies
Table 48: Social Performance of the Market for Insulin Drug and Delivery Technologies
Table 49: Governance Performance of the Market for Insulin Drug and Delivery Technologies
Table 50: Clinical Trials Involving Insulin Drug and Delivery Technologies
Table 51: Clinical Trials Involving Artificial Pancreas, as of December 2023
Table 52: Approved Active Patents for Insulin Drug Delivery Devices, 2021-2023
Table 53: M&A in the Global Market for Insulin Drug Delivery Devices, 2021 to June 2023
Table 54: Recent Venture Funding for Insulin Drug Delivery Devices and Related Offerings
Table 55: Number of Deals for Insulin Drug and Delivery Technologies, by Status, January 2018 to September 2023
Table 56: Leading Manufacturers and Suppliers of Insulin Syringes and Vials
Table 57: Ranking of Insulin Syringe Manufacturers, by Market Share, 2022
Table 58: Ranking of Insulin Vial Manufacturers, by Market Share, 2022
Table 59: Global Market Ranking for Insulin Drug Delivery Devices, 2022
Table 60: AstraZeneca: Company Snapshot
Table 61: AstraZeneca: Financial Performance, FY 2022-2023
Table 62: AstraZeneca: Product Portfolio
Table 63: AstraZeneca: Key/Recent Developments, 2021-2023
Table 64: B. Braun SE: Company Snapshot
Table 65: B. Braun SE: Financials, FY 2021-2022
Table 66: B. Braun SE: Product Portfolio
Table 67: B. Braun SE: News/Key Developments, 2023
Table 68: BD: Company Snapshot
Table 69: BD: Financial Performance, FY 2022-2023
Table 70: BD: Product Portfolio
Table 71: BD: News/Key Developments, 2021-2023
Table 72: Cardinal Health: Company Snapshot
Table 73: Cardinal Health: Financial Performance, FY 2022-2023
Table 74: Cardinal Health: Product Portfolio
Table 75: Cardinal Health: News/Key Developments, 2021-2023
Table 76: Debiotech SA: Company Snapshot
Table 77: Debiotech SA: Product Portfolio
Table 78: Debiotech SA: News/Key Developments, 2022-2023
Table 79: Diabeloop SA: Company Snapshot
Table 80: Diabeloop SA: Product Portfolio
Table 81: Diabeloop SA: News/Key Developments, 2021-2023
Table 82: Emperra GmbH E-Health Technologies: Company Snapshot
Table 83: Emperra GmbH E-Health Technologies: Product Portfolio
Table 84: Emperra GmbH E-Health Technologies: News/Key Developments, 2022
Table 85: Embecta Corp.: Company Snapshot
Table 86: Embecta Corp.: Financial Performance, FY 2022-2023
Table 87: Embecta Corp.: Product Portfolio
Table 88: Embecta Corp.: News/Key Developments, 2021-2023
Table 89: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 90: F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022-2023
Table 91: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 92: Insulet Corp.: Company Snapshot
Table 93: Insulet Corp.: Financial Performance, FY 2022-2023
Table 94: Insulet Corp.: Product Portfolio
Table 95: Insulet Corp.: News/Key Developments, 2023
Table 96: Johnson & Johnson Services Inc.: Company Snapshot
Table 97: Johnson & Johnson Services Inc.: Financial Performance, FY 2022-2023
Table 98: Johnson & Johnson Services Inc.: Product Portfolio
Table 99: Johnson & Johnson Services Inc.: News/Key Developments, 2021-2023
Table 100: LifeScan IP Holdings LLC.: Company Snapshot
Table 101: LifeScan IP Holdings LLC.: Product Portfolio
Table 102: LifeScan IP Holdings LLC.: News/Key Developments, 2021
Table 103: Lilly: Company Snapshot
Table 104: Lilly: Financial Performance, FY 2022-2023
Table 105: Lilly: Product Portfolio
Table 106: Lilly: Recent Developments, 2021-2022
Table 107: Medtronic: Company Snapshot
Table 108: Medtronic: Financial Performance, FY 2022-2023
Table 109: Medtronic: Product Portfolio
Table 110: Medtronic: News/Key Developments, 2021-2023
Table 111: Novo Nordisk A/S: Company Snapshot
Table 112: Novo Nordisk A/S: Financial Performance, FY 2022-2023
Table 113: Novo Nordisk A/S: Product Portfolio
Table 114: Novo Nordisk A/S: Recent Developments, 2021-2023
Table 115: NuGen Medical Devices: Company Snapshot
Table 116: NuGen Medical Devices: Financial Performance, FY 2021-2022
Table 117: NuGen Medical Devices: Product Portfolio
Table 118: NuGen Medical Devices: News/Key Developments, 2022
Table 119: Owen Mumford Ltd.: Company Snapshot
Table 120: Owen Mumford Ltd.: Product Portfolio
Table 121: Sanofi: Company Snapshot
Table 122: Sanofi: Financial Performance, FY 2022-2023
Table 123: Sanofi: Product Portfolio
Table 124: Sanofi: Recent Developments, 2022-2023
Table 125: Sooil Developments Co. Ltd.: Company Snapshot
Table 126: Sooil Developments Co. Ltd.: Product Portfolio
Table 127: Tandem Diabetes Care Inc.: Company Snapshot
Table 128: Tandem Diabetes Care Inc.: Financial Performance, FY 2022-2023
Table 129: Tandem Diabetes Care Inc.: Product Portfolio
Table 130: Tandem Diabetes Care Inc.: News/Key Developments, 2023-2024
Table 131: Terumo Corp.: Company Snapshot
Table 132: Terumo Corp.: Financial Performance, FY 2021-2022
Table 133: Terumo Corp.: Product Portfolio
Table 134: Terumo Corp.: News/Key Developments, 2022
Table 135: Ypsomed AG: Company Snapshot
Table 136: Ypsomed AG: Financial Performance, FY 2021-2022
Table 137: Ypsomed AG: Product Portfolio
Table 138: Ypsomed AG: News/Key Developments, 2022-2023
Table 139: Government Regulatory Agencies and Professional Organizations
List of Figures
Summary Figure: Global Market for Emerging Insulin Drug Delivery Devices, by Type, 2020-2028
Figure 1: Market Dynamics for Emerging Insulin Drug and Delivery Technologies
Figure 2: Snapshot of the Worldwide Incidence of Diabetes, 2019-2045
Figure 3: AstraZeneca: Revenue Share, by Segment, 2023
Figure 4: AstraZeneca: Revenue Share, by Region/Country, 2023
Figure 5: B. Braun SE: Revenue Share, by Business Unit, FY 2022
Figure 6: B. Braun SE: Revenue Share, by Region/Country, FY 2022
Figure 7: BD: Revenue Share, by Business Unit, FY 2023
Figure 8: BD: Revenue Share, by Region/Country, FY 2023
Figure 9: Cardinal Health: Revenue Share, by Business Unit, FY 2023
Figure 10: Cardinal Health: Revenue Share, by Region/Country, FY 2023
Figure 11: Embecta Corp.: Revenue Share, by Region/Country, FY 2023
Figure 12: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 13: F. Hoffmann-La Roche Ltd.: Revenue Share, by Region/Country, FY 2023
Figure 14: Insulet Corp.: Revenue Share, by Business Unit, FY 2023
Figure 15: Insulet Corp.: Revenue Share, by Region/Country, FY 2023
Figure 16: Johnson & Johnson Services Inc.: Revenue Share, by Business Unit, FY 2023
Figure 17: Johnson & Johnson Services Inc.: Revenue Share, by Region/Country, FY 2023
Figure 18: Lilly: Revenue Share, by Product Type, FY 2023
Figure 19: Lilly: Revenue Share, by Region/Country, FY 2023
Figure 20: Medtronic: Revenue Share, by Business Unit, FY 2023
Figure 21: Medtronic: Revenue Share, by Region/Country, FY 2023
Figure 22: Novo Nordisk A/S: Revenue Share, by Business Unit, FY 2023
Figure 23: Novo Nordisk A/S: Revenue Share, by Region/Country, FY 2023
Figure 24: NuGen Medical Devices: Revenue Share, by Region, FY 2022
Figure 25: Sanofi: Revenue Share, by Business Segment, FY 2023
Figure 26: Sanofi: Revenue Share, by Region, 2023
Figure 27: Tandem Diabetes Care Inc.: Revenue Share, by Region/Country, FY 2023
Figure 28: Terumo Corp.: Revenue Share, by Business Unit, FY 2022
Figure 29: Terumo Corp.: Revenue Share, by Region/Country, FY 2022
Figure 30: Ypsomed AG: Revenue Share, by Business Unit, FY 2022
Figure 31: Ypsomed AG: Revenue Share, by Region/Country, FY 2022
